Track market-moving stories before they get noisy

IT's rising client engagement, $5.3B contract value, stronger retention and higher 2026 guidance reinforce its long-term growth prospects.

Arlington, Virginia--(Newsfile Corp. - September 9, 2026) - Edge Total Intelligence Inc. (TSXV: CTRL) (OTCQB: UNFYF) (FSE: Q5I) ("edgeTI", "Company"), a provider of real-time digital operations software, today announced that edgeTI was recognized in the Digital Twins profile within the Gartner® Hype Cycle™ for Managing Operational Technology, 2026.

The report states, "Organizations are progressing in IT/OT alignment and integration maturity due to the convergence of technologies and overlap with systems and processes. This integration is driven by business goals such as intelligent operations, industrial safety, integrated processes, reduced cybersecurity risk and improved project agility, which deliver enterprise-level value. These require new support processes and shared IT and engineering skills through the formation of fusion teams."

edgeTI believes this recognition aligns with the Company's focus on helping customers compose legacy and modern systems into an operational digital twin that can unify data, applications, AI, automation, policy and human action in one governed environment.

"Operational leaders need a way to see, decide and act across increasingly complex physical and digital environments," said Jason Nichols, Chief Executive Officer of edgeTI. "We believe edgeCore is built for exactly that challenge: uniting bounded IT, OT and engineering data into a living operational model that supports faster decisions and accountable action. Building management is one microcosm of digital twins that has unique needs based on business use — for example residential high rise, schools, hospitals, laboratories manufacturing, logistics, office, mixed use. The permutations demand maximum flexibility."

edgeTI offers demonstrations and evaluations of edgeCore digital twin capabilities to prospective enterprise, government, defense, industrial and asset-intensive customers.

Gartner Attribution and Objectivity Disclaimer

Gartner, Hype Cycle for Managing Operational Technology, 2026, Kristian Steenstrup, Jo-Ann Clynch, 12 June 2026

GARTNER and Hype Cycle are registered trademarks and service marks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Edge Total Intelligence

edgeTI™ provides operational intelligence software and solutions for defense, maritime, manufacturing, critical infrastructure and government organizations whose systems by design cannot be consolidated. Its edgeCore™ platform creates a unified, real-time operational picture and enables governed action across those systems, with approvals, controls and evidence preserved. Customer data remains in place and under the customer's control. Having attained Technology Readiness Level 9, edgeTI solutions have been authorized to operate and deployed in classified environments. edgeTI is headquartered in Arlington, Virginia, with operations in the United States, Canada, Australia and Serbia.

Website: https://ir.edgeti.com
LinkedIn: www.linkedin.com/company/edgeti
YouTube: www.youtube.com/user/edgetechnologies

For more information, please contact:
Nick Brigman, Chief Strategy Officer and Corporate Secretary
Phone: 888-771-3343
Email: [email protected]

Forward-Looking Information and Statements
Certain statements in this news release are forward-looking statements or information for the purposes of applicable Canadian and US securities law. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such information can generally be identified by the use of forward-looking wording such as "may", "expect", "estimate", "anticipate", "intend", "believe" and "continue" or the negative thereof or similar variations. The reader is cautioned not to place undue reliance on any forward-looking information.

The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/313529

Source: Edge Total Intelligence Inc.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has approved ZANVASTRO™ (zilganersen) for the treatment of Alexander disease (AxD) in pediatric and adult patients. ZANVASTRO is the first and only disease modifying treatment for AxD, an ultra-rare, progressive and often fatal neurological disorder that can affect motor, cognitive, autonomic and gastrointestinal function. Until now, treatment of AxD has primarily been limited to managing symptoms. ZANVASTRO is an RNA-targeted medicine designed to address the underlying disease mechanism of AxD by reducing the production of glial fibrillary acidic protein (GFAP). ZANVASTRO 50 mg is administered quarterly as an intrathecal (IT) injection.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260903826844/en/

ZANVASTRO (zilganersen) logo

“Today’s approval of ZANVASTRO begins a new chapter for people living with Alexander disease and their families, who have long faced this relentlessly progressive and often fatal disease with no treatment options,” said Brett P. Monia, Ph.D., chief executive officer, Ionis. “This transformative approval also marks our first independent launch from our industry-leading neurology pipeline and underscores the power of our RNA-targeted technology to address serious neurological diseases without adequate treatment options. We are proud to bring this important new treatment to this incredible community and are deeply grateful to the clinical trial participants and their families, regulators, investigators and advocates who helped make this advancement possible.”

AxD affects approximately 1 in 1 to 3 million people worldwide. Initial signs of AxD can present from infancy through adulthood and may vary depending on age of onset. As AxD progresses, symptoms may include progressive motor and cognitive dysfunction, a loss of independence and the inability to control muscles for swallowing, airway protection and purposeful movements. AxD is caused by changes in the GFAP gene that lead to the overproduction and toxic accumulation of GFAP in astrocytes. Over time, dysfunction in astrocytes can damage neurons and myelin, which can lead to symptoms commonly associated with AxD.

“For decades, care for people living with Alexander disease has focused primarily on managing symptoms, without an option to modify the underlying cause of disease,” said Amy Waldman, M.D., M.S.C.E., pediatric neurologist and lead investigator for the ZANVASTRO study at Children’s Hospital of Philadelphia. “The approval of ZANVASTRO for the treatment of Alexander disease represents a significant advancement in care and opens new possibilities for patients and their families. For the first time, we can move beyond managing individual manifestations of the disease to addressing its underlying biology, with the potential to meaningfully improve outcomes for this community.”

“As a mom to a young boy living with Alexander disease and an advocate for this community, I have seen firsthand the profound impact this disease has on individuals and their families. Today’s approval represents a fundamental shift, changing the conversation from ‘How do we manage this disease’ to ‘How can we treat it,’” said Emily Petty, president, End Alexander Disease. “For far too long, receiving a diagnosis of Alexander disease was accompanied by uncertainty and the difficult reality that there were no available treatments. Today, that begins to change. ZANVASTRO marks a defining moment and brings a new sense of possibility to our community.”

The FDA approval was based on positive results from the pivotal study of ZANVASTRO in people living with AxD. The pivotal study met its primary endpoint in individuals ≥ 5 years of age, with ZANVASTRO 50 mg demonstrating statistically significant and clinically meaningful stabilization of gait speed as assessed by the 10-Meter Walk Test (10MWT), a commonly used measure of gross motor function in neurologic disease, compared to control at Week 61 (least square mean difference 33.3%, p=0.041). ZANVASTRO also demonstrated improvement in gross motor function in patients 2 to 4 years of age as assessed by the Gross Motor Function Measure-88 (GMFM-88), a well-established motor endpoint, compared to control at Week 61. Secondary and exploratory endpoint results from patient/caregiver- and clinician-reported outcome assessments consistently favored ZANVASTRO.

ZANVASTRO demonstrated a favorable safety and tolerability profile, with most adverse events (AEs) being mild or moderate in severity. Serious treatment-emergent adverse events (TEAEs) occurred less frequently in the ZANVASTRO group compared to control.

Ionis is committed to helping people access the medicines they are prescribed and will offer a full suite of services for people prescribed ZANVASTRO through Ionis Every Step™. As part of Ionis Every Step, patients will have access to a wide range of support and resources including disease state and product education for patients and caregivers, access to a dedicated Patient Education Manager, assistance with the insurance approval process, information on affordability programs and other ongoing services and resources throughout the treatment journey. Visit ZANVASTRO.com for more information.

With the approval of ZANVASTRO, the FDA granted Ionis a Rare Pediatric Disease Priority Review Voucher (PRV), a program designed to incentivize the development of therapies for serious and life-threatening diseases by providing a mechanism to potentially accelerate regulatory review timelines for subsequent applications.

ZANVASTRO will be available in the U.S. in the coming weeks.

In June 2026, Ionis entered into a license agreement with Recordati, a global pharmaceutical company headquartered in Italy, focused on specialty and rare diseases, under which Recordati obtained exclusive rights to develop and commercialize zilganersen in all countries outside the U.S. Ionis is working closely with Recordati on preparing regulatory submissions in Europe and Japan, which are expected in 2027.

Webcast

Ionis will hold a webcast on Friday, Sept. 4 at 10:00 a.m. ET to discuss the FDA approval. Interested parties may access the webcast here. A webcast replay will be available for a limited time.

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS
Aseptic Meningitis

If symptoms consistent with aseptic meningitis develop, diagnostic workup and treatment should be initiated according to the standard of care.

Adverse reactions of aseptic meningitis (also called chemical meningitis or drug-induced aseptic meningitis) were reported in patients treated with ZANVASTRO during the double-blind and open-label periods of Study 1. One patient experienced a serious adverse reaction of aseptic meningitis during the double-blind treatment period of Study 1, which reoccurred in the open-label extension period and required dose interruption and pretreatment with intravenous dexamethasone prior to subsequent administration of ZANVASTRO. Despite corticosteroid premedication, CSF white blood cell (WBC) and protein increased with continued exposure, but the patient remained asymptomatic and did not require discontinuation from treatment. In addition, nonserious adverse drug reactions of CSF WBC increases have also been reported with ZANVASTRO.

ADVERSE REACTIONS

Most common adverse reactions (incidence ≥25% patients treated with ZANVASTRO and greater than control) were vomiting, back pain, cough, headache, and post-lumbar puncture syndrome.

Patients Less Than 2 Years of Age
The adverse reactions of patients less than 2 years of age are expected to be similar to that of pediatric patients 2 years of age and older.

Please see full Prescribing Information for ZANVASTRO.

About the ZANVASTRO Study

The global, multicenter, randomized, double-blind, controlled, multiple-ascending dose (MAD) Phase 1-3 study (NCT04849741) enrolled 54 participants with Alexander disease (AxD) between the ages of 1.5 and 53 years across 13 sites in eight countries. Most participants in the study were children, reflecting the early onset and severe progression of AxD in pediatric populations. Participants were randomized in a 2:1 ratio to receive ZANVASTRO or control for a 60-week double-blind treatment period. The study included two dose cohorts, 25 mg and 50 mg, with the 50 mg dose cohort analyzed as the pivotal dose cohort, with dosing every 12 weeks. At week 60, eligible participants entered a 60-week open-label treatment period, followed by a 120-week open-label long-term extension period. During the long-term extension, participants in the 25 mg dose cohort transitioned to the 50 mg dose cohort. Participants in countries where zilganersen has not been or is not commercially available can continue to receive zilganersen treatment through a 240-week extended long-term extension period, which includes 20 additional doses, followed by a 28-week post-treatment follow-up period. The primary endpoint was percent change from baseline in gait speed as assessed by the 10-Meter Walk Test (10MWT), an assessment of functional mobility, at the end of the double-blind treatment period. Key secondary endpoints include patients' self-identified Most Bothersome Symptom (MBS) Score, change from baseline in Patient Global Impression of Severity (PGIS) Score and Patient Global Impression of Change (PGIC) Score and Clinician Global Impression of Change (CGIC) Score at the end of the double-blind treatment period.

About Alexander Disease (AxD)

AxD is an ultra-rare, progressive and often fatal neurological disease that occurs in approximately 1 per 1 to 3 million people worldwide and affects a type of cell in the brain called astrocytes. Astrocytes have multiple roles in the brain including support of neurons and oligodendrocytes, which maintain the myelin sheath around nerve fibers. AxD is caused by disease-causing variants in the glial fibrillary acidic protein (GFAP) gene and is generally characterized by progressive neurological deterioration resulting in loss of functional mobility, loss of independence and the inability to control muscles for large movements, swallowing and airway protection, though symptoms can vary depending on age of onset. AxD usually leads to death within 14 - 25 years after symptom onset.

About ZANVASTROTM (zilganersen)

ZANVASTROTM (zilganersen)is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alexander disease (AxD) in pediatric and adult patients. ZANVASTRO is an RNA-targeted therapy designed to inhibit production of excess glial fibrillary acidic protein (GFAP) that accumulates as a result of pathogenic variants in the GFAP gene. For more information about ZANVASTRO, visit ZANVASTRO.com.

About Ionis Neurology

Ionis has been at the forefront of discovering and developing leading neurological disease medicines, including ZANVASTROTM (zilganersen), the only approved treatment for Alexander disease, SPINRAZA® (nusinersen), the first approved treatment for spinal muscular atrophy, WAINUA® (eplontersen), a medicine to treat hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN), and QALSODY® (tofersen) for SOD1-ALS. The clinical-stage portfolio includes 12 investigational medicines, of which seven are wholly owned by Ionis. Ionis' investigational portfolio includes medicines for which there are few or no disease modifying treatments, such as rare diseases including Angelman syndrome, prion disease and multiple system atrophy, as well as more common conditions like Alzheimer's disease.

About Ionis Pharmaceuticals, Inc.

For more than three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has marketed medicines and a leading pipeline in neurology, cardiometabolic disease and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter), LinkedIn and Instagram.

Ionis Forward-looking Statements

This press release includes forward-looking statements regarding Ionis' business and the therapeutic and commercial potential of ZANVASTRO, Ionis' technologies and other products in development and our expectations regarding development and regulatory milestones. Any statement describing Ionis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties including those inherent in the process of discovering, developing and commercializing medicines that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such medicines. Ionis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Ionis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Ionis. Except as required by law, we undertake no obligation to update any forward-looking statements for any reason. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Ionis' programs are described in additional detail in Ionis' annual report on Form 10-K for the year ended December 31, 2025, and most recent Form 10-Q, which are on file with the Securities and Exchange Commission. Copies of these and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Ionis," "Company," "we," "our" and "us" all refer to Ionis Pharmaceuticals and its subsidiaries.

Ionis Pharmaceuticals® is a registered trademark of Ionis Pharmaceuticals, Inc. ZANVASTROTM and Ionis Every StepTM are trademarks of Ionis Pharmaceuticals, Inc. QALSODY® and SPINRAZA® are registered trademarks of Biogen. WAINUA® is a registered trademark of the AstraZeneca group of companies.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260903826844/en/

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary duty by certain directors and officers of Gartner, Inc. (“Gartner” or the “Company”) (NYSE: IT). The investigation seeks to determine whether the Company’s leadership fulfilled its obligations to shareholders and whether legal remedies may be available.

Current Gartner Shareholders Are Encouraged to Contact the Firm

Do you currently own shares of Gartner, Inc. (NYSE: IT)?Did you purchase your shares before February 24, 2025?Would you like to learn more about your legal rights as a shareholder?
Why Is Bernstein Liebhard Investigating?

Bernstein Liebhard is investigating whether certain directors and officers of Gartner breached the fiduciary duties they owed to the Company and its shareholders. The investigation is focused on determining whether Company leadership acted in the best interests of shareholders and whether additional legal action may be appropriate based on publicly available information.

What Shareholders Should Do

If you currently own Gartner stock and would like to discuss your legal rights or obtain additional information regarding the investigation, please visit the firm’s Gartner Shareholder Investigation page or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or [email protected] for a confidential consultation.

About Bernstein Liebhard LLP

For more than three decades, Bernstein Liebhard LLP has represented investors in complex securities and shareholder litigation. Since 1993, the firm has recovered more than $3.5 billion for its clients and has been retained by many of the nation’s largest public and private pension funds to monitor investments and pursue claims on behalf of investors.

The firm’s accomplishments include recognition on The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and inclusion in The Legal 500 for sixteen consecutive years, reflecting its longstanding commitment to protecting shareholder rights.

ATTORNEY ADVERTISING. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Peter Allocco
Investor Relations Manager
Bernstein Liebhard LLP
10 East 40th Street
New York, NY 10016
Phone: (212) 951-2030
Website: https://www.bernlieb.com
Email: [email protected]

Key Takeaways Gartner stock rose 28.4% in three months, outpacing its industry's 13% rally and the S&P 500.Gartner beat Q1 and Q2'26 EPS estimates and lifted its 2026 adjusted EPS outlook to at least $14.Gartner repurchased 3.6M shares for $547M and raised buyback authorization to $1.2B. Gartner, Inc. (IT - Free Report) stock has gained 28.4% over the past three months, outperforming the industry’s 13% rally and the Zacks S&P 500 Composite's marginal return.

3-Month Share Price Performance                                                                 Image Source: Zacks Investment Research

Let us delve deeper into the factors that have contributed to the company’s outperformance.

Differentiated Product Portfolio Facilitates Steady RevenueOperating in an industry with low barriers to entry, Gartner has a differentiated product portfolio and an integrated research and consulting team created to serve diverse client requirements best. It provides a competitive edge against its rivals.

Leveraging its intellectual capital, Gartner creates and distributes proprietary research content as broadly as possible via published reports, interactive tools, facilitated peer networking, briefings, consultancy and advisory services, and events. These facilitate a steadily improving revenue stream for the company, as evidenced by year-over-year growth of 7.9%, 6.1% and 3.7%.

                                                                 Image Source: Zacks Investment Research

Persistent Earnings Beat & Upward Outlook RevisionGartner reported earnings of $3.32 per share during the first quarter of 2026, beating the consensus estimate by 11%. For the second quarter, the company maintained its performance as its earnings beat the consensus estimate by 15.9%. Management’s optimism peaked as it raised the adjusted EPS outlook for 2026 to at least $14 during the second quarter of 2026 from the preceding quarter’s view of at least $13.25.

                                                                 Image Source: Zacks Investment Research

Consistency in earnings beats, accompanied by management’s confidence in bottom-line growth, raises shareholder morale, prompting them to invest in the stock.

Shareholder-Friendly ActionsGartner executed a significant share repurchase in the second quarter of 2026, amounting to 3.6 million shares for $547 million. It resulted in a sharp 16.2% year-over-year decline in shares outstanding, driving the bottom line by 33.1%. This action underscores management’s focus on creating long-term shareholder value. The board of directors increased buyback authorization by $500 million to $1.2 billion in July 2026, raising investor morale.

Zacks Rank & Stocks to ConsiderGartner currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Some higher-ranked stocks in the broader Zacks Business Services sector are The Geo Group (GEO - Free Report) and ScanSource (SCSC - Free Report) , each currently sporting a Zacks Rank #1.

The Geo Group has a long-term earnings growth expectation of 14%. GEO delivered a trailing four-quarter earnings surprise of 24.6%, on average.

ScanSource has a long-term earnings growth expectation of 15%. SCSC delivered a trailing four-quarter earnings surprise of 7.8%, on average.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.

It also includes access to the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.

Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.

The Style Scores are broken down into four categories:

Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.

Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.

Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.

VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.

It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.8% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.

For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Gartner (IT - Free Report) Headquartered in Stamford, Connecticut, Gartner, Inc. is reportedly the world's leading information technology research and advisory firm. The company offers rich domain expertise and technology-related insight necessary for an informed decision-making process.

IT is a #1 (Strong Buy) on the Zacks Rank, with a VGM Score of B.

It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 13.59; value investors should take notice.

Six analysts revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.77 to $14.42 per share. IT also boasts an average earnings surprise of +13.5%.

With a solid Zacks Rank and top-tier Value and VGM Style Scores, IT should be on investors' short list.

New York, New York--(Newsfile Corp. - August 18, 2026) - Bernstein Liebhard LLP, a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary duty by certain directors and officers of Gartner, Inc. ("Gartner" or the "Company") (NYSE: IT). The investigation seeks to determine whether the Company's leadership fulfilled its obligations to shareholders and whether legal remedies may be available.

Current Gartner Shareholders Are Encouraged to Contact the Firm

Do you currently own shares of Gartner, Inc. (NYSE: IT)?Did you purchase your shares before February 24, 2025?Would you like to learn more about your legal rights as a shareholder?Why Is Bernstein Liebhard Investigating?

Bernstein Liebhard is investigating whether certain directors and officers of Gartner breached the fiduciary duties they owed to the Company and its shareholders. The investigation is focused on determining whether Company leadership acted in the best interests of shareholders and whether additional legal action may be appropriate based on publicly available information.

What Shareholders Should Do

If you currently own Gartner stock and would like to discuss your legal rights or obtain additional information regarding the investigation, please visit the firm's Gartner Shareholder Investigation page or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or [email protected] for a confidential consultation.

About Bernstein Liebhard LLP

For more than three decades, Bernstein Liebhard LLP has represented investors in complex securities and shareholder litigation. Since 1993, the firm has recovered more than $3.5 billion for its clients and has been retained by many of the nation's largest public and private pension funds to monitor investments and pursue claims on behalf of investors.

The firm's accomplishments include recognition on The National Law Journal's "Plaintiffs' Hot List" thirteen times and inclusion in The Legal 500 for sixteen consecutive years, reflecting its longstanding commitment to protecting shareholder rights.

ATTORNEY ADVERTISING. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/310253

Source: Bernstein Liebhard LLP

Gartner (IT +0.42%) stock surged this week after the information services specialist reported better-than-expected quarterly results. The company's share price climbed 22.9% in the week amid the backdrop of a 3.6% gain for the S&P 500 and a 5.2% gain for the Nasdaq Composite.

Gartner's valuation has been under pressure over the last year due to concerns that artificial intelligence (AI) will disrupt its business, but the company's second-quarter results were better than anticipated. The company also raised its full-year guidance and continued to expand its share buyback program.

Image source: Getty Images.

Gartner delivered a big earnings beat in Q2 In the second quarter, Gartner posted non-GAAP (adjusted) earnings per share of $4.37 on revenue of approximately $1.7 billion. The company's adjusted profit per share was $0.64 better than the average Wall Street analyst estimate, and sales came in $50 million ahead of the average target. While revenue was only up 0.6% year over year, free cash flow and net income were up 8.9% and 14.4%, respectively.

Today's Change

(

0.42

%) $

0.78

Current Price

$

185.60

What's next for Gartner? Gartner provided updated full-year guidance with its Q2 report, and the update was largely positive. While the company lowered its full-year adjusted revenue guidance from $5.2 billion to $5.17 billion, this was due to adverse foreign exchange impacts. The big upside was that the information services leader delivered significant increases in its earnings and free cash flow targets.

Gartner now expects adjusted earnings of $14 per share for the year -- up from its previous target for per-share earnings of $13.25. Meanwhile, free cash flow for the year is now projected to be $1.185 billion -- up from $1.16 billion. Gartner's board of directors has also increased the company's share repurchase authorization by another $500 million. With the company delivering improved operating efficiency and ramping up buybacks, the business could continue to see relatively strong earnings growth.

Keith Noonan has no position in any of the stocks mentioned. The Motley Fool recommends Gartner. The Motley Fool has a disclosure policy.

Key Takeaways Gartner raised 2026 adjusted EPS guidance to at least $14 and free cash flow to at least $1.185B.Gartner cut adjusted revenue guidance to at least $6.375B as Consulting revenues fell 8.8% in Q2.Gartner's Q2 adjusted EBITDA margin rose to 27.8%, while buybacks helped adjusted EPS climb 23.8%. Gartner, Inc. (IT - Free Report) raised its 2026 profit and cash-flow expectations even as it lowered its adjusted revenue outlook. The divergence shifts investor attention toward cost control, margins and capital allocation.

The key question is whether those levers can keep supporting per-share earnings while top-line growth remains restrained.

Gartner Raises Its 2026 Profit ExpectationsGartner lifted adjusted EPS guidance to at least $14 from $13.25. Adjusted EBITDA excluding the divested operation is now expected to reach at least $1.570 billion, up from $1.545 billion previously.

Free cash flow guidance also increased to at least $1.185 billion from $1.160 billion. The higher targets point to greater confidence in profitability and cash generation despite a more measured revenue outlook.

IT Trims Its Revenue OutlookAdjusted revenue guidance declined to at least $6.375 billion from $6.405 billion. The Insights revenue outlook also moved lower to at least $5.170 billion from $5.200 billion.

The simultaneous profit upgrade and revenue reduction puts more weight on operating efficiency and business mix. Gartner said expenses reflect agile cost management while it continues investing in experts and artificial intelligence to support future top-line growth.

Gartner’s Q2 Margins Show Why Profits Can RiseSecond-quarter adjusted EBITDA excluding the divested operation increased 6.4% to $466 million. The corresponding margin reached 27.8%, expanding 90 basis points year over year.

GAAP operating income rose to $378.5 million from $327.1 million. Operating margin improved to 22.6% from 19.4%, reinforcing the margin expansion behind the higher full-year profit expectations.

IT’s Segment Mix Creates Both Support and PressureInsights revenues rose 2.1% to $1.290 billion, while Conferences revenues increased 15.5% to $244 million. Conferences contribution margin reached 59.5%, up from 57.4% a year earlier.

Consulting revenues fell 8.8% to $142 million and contribution declined 12.6% to $54 million. Forrester Research, Inc. (FORR - Free Report) , an independent research and advisory firm, is a relevant peer for the Insights business. Accenture plc (ACN - Free Report) , which offers broad consulting and technology services, provides context for Gartner’s Consulting exposure.

Gartner’s Cash Flow and Buybacks Add LeverageSecond-quarter free cash flow increased 8.9% to $378 million. Gartner also repurchased 3.6 million shares for $547 million during the quarter, while its board increased the repurchase authorization by $500 million in July.

Adjusted EPS rose 23.8% to $4.37, faster than the 6.6% increase in adjusted net income to $291 million. The diluted share count fell to 66.6 million from 77.4 million, showing how buybacks amplified per-share growth.

                                                                 Image Source: Zacks Investment Research

IT’s Positive Signals Reinforce the Profit StoryGartner’s raised earnings and free cash flow outlook, wider margins and lower share count support the profit case, but slower revenue expectations keep execution risk in focus. Improvement in Consulting and sustained margin discipline remain important variables.

The stock currently carries a Zacks Rank #1 (Strong Buy), You can see the complete list of today’s Zacks #1 Rank stocks here.It carries a Value Score of A and VGM Score of A. It also has a Growth Score of B and Momentum Score of B.

The Zacks Rank places IT among the top-ranked stocks based on earnings estimate revisions, while the A and B Style Scores indicate favorable value, growth and momentum characteristics. These signals are positive, but revenue growth and segment execution still warrant monitoring.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.

Zacks Premium includes access to the Zacks Style Scores as well.

What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.

Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.

The Style Scores are broken down into four categories:

Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.

Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.

Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.

VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.

It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.

A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Gartner (IT - Free Report) Headquartered in Stamford, Connecticut, Gartner, Inc. is reportedly the world's leading information technology research and advisory firm. The company offers rich domain expertise and technology-related insight necessary for an informed decision-making process.

IT is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

Additionally, the company could be a top pick for growth investors. IT has a Growth Style Score of A, forecasting year-over-year earnings growth of 4.9% for the current fiscal year.

One analyst revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.10 to $13.81 per share. IT boasts an average earnings surprise of +13.5%.

With a solid Zacks Rank and top-tier Growth and VGM Style Scores, IT should be on investors' short list.

-

Analysts to Discuss How Leaders Can Harness AI and Data and Analytics, and Demonstrate Business Value in Today’s Rapidly Evolving Risk Landscape

LONDON--(BUSINESS WIRE)--Gartner (NYSE: IT):

What:

Gartner Enterprise Risk, Audit & Compliance Conference

When:

September 28-29, 2026

Where:

Park Plaza Westminster

200 Westminster Bridge Road

London, England SE1 7UT United Kingdom

Details:
Gartner analysts will explore the theme “From Risk Insight to Action” during the Gartner Enterprise Risk, Audit & Compliance Conference 2026. Assurance leaders will learn how to advance their strategy, harness AI, data and analytics in their function, demonstrate greater business value, and increase their team’s impact in today’s changeable risk landscape.

Audience and Topics:
The conference agenda covers the latest hot topics relevant to enterprise risk, audit and compliance leaders. View the full agenda to learn more about the conference experience.

Highlights of conference sessions include:

Audit 2030: Key Trends Shaping the Future of Internal Audit The Executive Guide to AI Governance for Assurance Leaders Building Dynamic Compliance Guidance With GenAI Building Smart Data Governance for an AI-Driven Enterprise How to Scale Aligned Assurance for an Interconnected Landscape Keynotes & Guest Speakers:

Gartner Opening Keynote: Co-Managing Risk: How Risk Leaders and AI Partner to Transform Business Risk Ownership with Nancy Queally, Managing Vice President at Gartner, and Tegan Gebert, Vice President Advisor at Gartner. Guest Keynote: Navigating the Multi-Generational Workplace with Dr. Paul Redmond, who regularly advises companies and organisations on how to establish, develop and maintain an engaged workforce. Guest Keynote: Leading Beyond the Buzzword Economy with Magnus Lindkvist, a trendspotter and futurologist who weaves together the most important and exciting current trends to forecast what life, society and business might look like in the future. Exhibitor Showcase
Attendees will get exclusive access to live demos and peers case studies from solution providers at the forefront of finance technology. They will have the opportunity to evaluate the solution providers and learn the best implementation practices.

Registration
To register and to find complete conference details, please visit the Gartner Enterprise Risk, Audit & Compliance Conference website.

Member of the media can register for the conference by contacting Rob van der Meulen at [email protected].

Social Media: Join the discussion on social media using #GartnerERAC.

Gartner is the World Authority on AI
Gartner is an indispensable partner to C-Level executives and technology providers as they implement AI strategies to achieve their mission-critical priorities. The independence and objectivity of Gartner insights provide clients with the confidence to make informed decisions and unlock the full potential of AI. Clients across the C-Level are using Gartner's proprietary AskGartner AI tool to determine how to leverage AI in their business. With more than 2,500 business and technology experts, 6,000 written insights, as well as more than 4,000 AI use cases and case studies, Gartner is the world authority on AI. More information can be found here.

About the Gartner Enterprise Risk, Audit & Compliance Conference
Taking place in Grapevine, Texas on September 15-16, 2026, and London on September 28-29, 2026, the Gartner Enterprise Risk, Audit & Compliance Conference will explore how assurance leaders can translate risk insight into decisive business action in an increasingly dynamic environment. Under the theme “From Risk Insight to Action,” the conference will highlight how progressive risk, audit, and compliance leaders are strengthening organizational risk reflexes, enabling faster and more effective responses to emerging threats while elevating the role of assurance within the business. Follow news and updates from the conferences on X and LinkedIn using the hashtag #GartnerERAC.

About Gartner for Legal, Risk & Compliance Leaders
Gartner for Legal, Risk and Compliance Leaders provides expert guidance and tools to help leaders across legal, risk, audit and compliance departments more effectively manage an increasingly complex risk landscape and build next-generation functions. Additional information is available at gartner.com/en/audit-risk and gartner.com/en/legal-compliance. Follow news and updates on LinkedIn and X. Visit the Gartner Legal and Compliance Newsroom for more information and insights.

About Gartner
Gartner (NYSE: IT) delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. To learn more visit gartner.com.

More News From Gartner, Inc.

Back to Newsroom

Key Takeaways Gartner's adjusted EPS rose 23.8% YoY as second-quarter revenues reached $1.68 billion. Contract value grew 1.7% to $5.28 billion as subscription demand gradually stabilized. 2026 adjusted EPS guidance rose to at least $14, while free cash flow guidance increased to $1.19B. Gartner, Inc. (IT - Free Report) reported better-than-expected second-quarter 2026 results, with both earnings and revenues surpassing the Zacks Consensus Estimate.

Adjusted earnings of $4.37 per share beat the consensus estimate of $3.77 by 15.9% and increased 23.8% from the year-ago quarter’s $3.53. The improvement reflected higher operating profit and a considerably lower diluted share count.

Revenues of $1.68 billion surpassed the consensus mark of $1.65 billion by 1.8%. Reported revenues declined 0.6% year over year because the prior-year period included revenues from the divested Digital Markets operation. Adjusted revenues increased 2.8% on a reported basis and 1.8% on a foreign-currency-neutral basis.

IT’s Contract Value Growth AcceleratesGlobal contract value reached $5.28 billion, increasing 1.7% year over year and 0.3% sequentially on a foreign-currency-neutral basis. The improvement from 1% year-over-year growth in the first quarter indicates that subscription demand is gradually stabilizing.

Global Technology Sales contract value was approximately $4 billion, rising 1.1% year over year and remaining nearly flat sequentially. Global Business Sales contract value increased 3.3% year over year and 1.2% sequentially to $1.28 billion.

Global wallet retention was 98.2%, up from 97.7% in the preceding quarter but below 101.3% a year earlier. Client retention improved sequentially to 85.2% from 85%, compared with 84.6% in the year-ago quarter. Contract value per enterprise advanced to $414,000 from $376,000 a year ago, partly offsetting a 4.5% decline in client enterprises to 12,775.

Gartner’s Q2 Segmental PerformanceInsights revenues increased 2.1% year over year, or 1% on a foreign-currency-neutral basis, to $1.29 billion. Segment contribution rose 4% to $999 million. The contribution margin expanded 150 basis points to 77.5%, demonstrating the scalability of Gartner’s subscription-oriented research platform.

Conferences delivered the strongest revenue growth. Segment revenues advanced 15.5% year over year, or 14.2% on a foreign-currency-neutral basis, to $244 million. Contribution jumped 19.6% to $145 million, while the contribution margin expanded 210 basis points to 59.5%.

Same-conference revenues increased 12%, although attendee levels declined 1.4%. Gartner held 18 destination conferences during the quarter compared with 19 a year earlier, while destination conference attendance decreased slightly to 28,057 from 28,295.

Consulting remained the weakest segment. Revenues declined 8.8% year over year to $142 million, while contribution fell 12.6% to $54 million. The contribution margin contracted 170 basis points to 37.9%.

Labor-based consulting revenues decreased 12.8% to $96 million, whereas contract optimization revenues increased 0.9% to $46 million. Consulting backlog rose 9.1% to $214 million, offering some support for future revenues. Billable headcount fell 11.3% to 842, while utilization improved 32 basis points to 65.1%.

IT’s Profitability and Cash Flow ImproveAdjusted EBITDA excluding the divested operation increased 6.4% year over year, or 4.4% on a foreign-currency-neutral basis, to $466 million. The corresponding margin expanded 90 basis points to 27.8%.

GAAP operating income advanced 15.7% to $378.5 million. The operating margin improved to 22.6% from 19.4% a year earlier, aided by lower service, product-development and administrative expenses.

Net income increased 14.4% to $275.5 million. Earnings climbed 33.1% to $4.14 per share, with the faster per-share increase supported by a reduction in shares to 66.6 million from 77.4 million.

Operating cash flow rose 3.8% to $398 million. With capital expenditures declining to $20 million from $36 million, free cash flow increased 8.9% to $378 million. The trailing-12-month free cash flow was approximately $1.3 billion.

Gartner repurchased 3.6 million shares for $547 million during the quarter. Year-to-date repurchases totaled approximately $1.08 billion. The company had about $1.2 billion remaining under its repurchase authorization as of July 31 after the board approved an additional $500 million in July.

Gartner ended the quarter with $1.49 billion in cash and approximately $3 billion in debt. Gross debt to adjusted EBITDA was 1.8 times, while net leverage stood at 0.9 times.

Gartner’s 2026 GuidanceGartner now expects 2026 adjusted revenues of at least $6.38 billion, compared with the previous outlook of $6.41 billion.

Insights revenues are now projected to be at least $5.17 billion, down from the prior guidance of $5.20 billion. The outlooks for Conferences and Consulting revenues were maintained at no less than $695 million and $510 million, respectively.

Despite the revenue adjustment, the company raised its profitability forecast. Adjusted EBITDA excluding the divested operation is now expected to be at least $1.57 billion, up from $1.55 billion. Adjusted EPS guidance for 2026 increased to a minimum of $14 from $13.25, while the free cash flow forecast rose to at least $1.19 billion from $1.16 billion.

Gartner carries a Zacks Rank #4 (Sell) at present.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Recent Earnings SnapshotWaste Connections, Inc. (WCN - Free Report) reported second-quarter 2026 adjusted earnings of $1.50 per share, beating the Zacks Consensus Estimate of $1.35 by 11.1%. Earnings increased 16.3% from $1.29 in the year-ago quarter.

Revenues of $2.56 billion surpassed the consensus estimate of $2.53 billion by 1.1% and rose 6.4% year over year.

Equifax Inc. (EFX - Free Report) reported second-quarter 2026 adjusted earnings of $2.25 per share, up 12.5% year over year. The figure beat the Zacks Consensus Estimate of $2.21 by 1.8%.

Revenues increased 10.6% year over year to $1.7 billion and surpassed the consensus mark by a slight margin.

After trading flat yesterday, Gartner Inc. (IT +17.81%) stock is making a notable move higher today. The business intelligence specialist announced second-quarter 2026 financial results before the market opened this morning, and investors are clearly impressed with what Gartner reported.

As of 11:13 a.m. ET, shares of Gartner are up 15.9%.

Image source: Getty Images.

A drop in revenue isn't dissuading investors from clicking the buy button Exceeding the expectations of analysts that it would report $1.65 billion on the top line, Gartner posted $1.68 billion in revenue for Q2 2026, a 0.6% year-over-yer decrease.

Today's Change

(

17.81

%) $

26.99

Current Price

$

178.52

At the bottom of the income statement, the company reported even more surprising results. Gartner booked adjusted earnings per share (EPS) of $4.37, significantly better than the $3.73 that analysts had anticipated.

In addition to the Q2 2026 results, Gartner provided an update to 2026 guidance. Whereas it had originally forecast 2026 adjusted EPS of $13.25, it now forecasts $14. Plus, it raised 2026 free cash flow guidance to $1.19 billion from $1.16 billion.

Is it too late to buy Gartner stock? Despite the major move in Gartner's stock, investors who have the tech stock on their radars have a great opportunity to buy now. The tech stock is currently sitting in the bargain bin. Currently, shares of Gartner are trading at 8.4 times operating cash flow, a deep discount to their five-year average cash flow multiple of 19.6.

Scott Levine has no position in any of the stocks mentioned. The Motley Fool recommends Gartner. The Motley Fool has a disclosure policy.

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary duty by certain directors and officers of Gartner, Inc. (“Gartner” or the “Company”) (NYSE: IT). The investigation seeks to determine whether the Company’s leadership fulfilled its obligations to shareholders and whether legal remedies may be available.

Current Gartner Shareholders Are Encouraged to Contact the Firm

Do you currently own shares of Gartner, Inc. (NYSE: IT)?Did you purchase your shares before February 24, 2025?Would you like to learn more about your legal rights as a shareholder?
Why Is Bernstein Liebhard Investigating?

Bernstein Liebhard is investigating whether certain directors and officers of Gartner breached the fiduciary duties they owed to the Company and its shareholders. The investigation is focused on determining whether Company leadership acted in the best interests of shareholders and whether additional legal action may be appropriate based on publicly available information.

What Shareholders Should Do

If you currently own Gartner stock and would like to discuss your legal rights or obtain additional information regarding the investigation, please visit the firm’s Gartner Shareholder Investigation page or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or [email protected] for a confidential consultation.

About Bernstein Liebhard LLP

For more than three decades, Bernstein Liebhard LLP has represented investors in complex securities and shareholder litigation. Since 1993, the firm has recovered more than $3.5 billion for its clients and has been retained by many of the nation’s largest public and private pension funds to monitor investments and pursue claims on behalf of investors.

The firm’s accomplishments include recognition on The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and inclusion in The Legal 500 for sixteen consecutive years, reflecting its longstanding commitment to protecting shareholder rights.

ATTORNEY ADVERTISING. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Peter Allocco
Investor Relations Manager
Bernstein Liebhard LLP
10 East 40th Street
New York, NY 10016
Phone: (212) 951-2030
Website: https://www.bernlieb.com
Email: [email protected]

Diluted EPS: $4.14, +33.1%; Adjusted EPS: $4.37, +23.8%

Contract Value, FX Neutral: $5.3 billion, +0.3% Sequentially, +1.7% YoY

SECOND QUARTER 2026 HIGHLIGHTS

Revenues: $1.7 billion, -0.6% as reported; -1.6% FX neutral. Adjusted Revenues: $1.7 billion, +2.8% as reported; +1.8% FX neutral. Net income: $275 million, +14.4% as reported; Adjusted EBITDA excluding divested operation: $466 million, +6.4% as reported, +4.4% FX neutral. Operating cash flow: $398 million, +3.8%; free cash flow: $378 million, +8.9%. Repurchased 3.6 million common shares for $547 million. Board of Directors increased the share repurchase authorization by $500 million in July 2026. STAMFORD, Conn.--(BUSINESS WIRE)--Gartner, Inc. (NYSE: IT) today reported results for the second quarter of 2026 and updated its financial outlook for the full year 2026. Additional information regarding the Company’s results as well as the updated 2026 financial outlook is provided in an earnings supplement available on the Company’s Investor Relations website at https://investor.gartner.com.

Gene Hall, Gartner’s Chairman and Chief Executive Officer, commented, "Contract Value growth accelerated again. Revenues, Adjusted EBITDA excluding divested operation, Adjusted EPS, and free cash flow were ahead of expectations. We repurchased $547 million of stock in the quarter, as our capital allocation continues to create value for our shareholders. In addition, we increased our full year Adjusted EBITDA excluding divested operation, Adjusted EPS, and free cash flow guidance even with the stronger dollar."

CONFERENCE CALL INFORMATION

The Company will host a webcast call at 8:00 a.m. Eastern time on Tuesday, August 4, 2026 to discuss the Company’s financial results. Listeners can access the webcast live at https://edge.media-server.com/mmc/p/siaqzruh. To participate actively in the live call via dial-in, please register at https://register-conf.media-server.com/register/BI60b3b327155d48c99835471ca69f3102. Once registered, participants will receive a dial-in number and a unique PIN to access the call. A replay of the webcast will be available on the Company’s website for approximately 30 days following the call.

CONSOLIDATED RESULTS HIGHLIGHTS

(Unaudited; $ in millions, except per share amounts)

Three Months Ended

June 30,

Inc/(Dec)

2026

2025

Inc/(Dec)

FX Neutral

GAAP Metrics:

Revenues

$

1,676

$

1,686

(0.6

)%

(1.6

)%

Net income

275

241

14.4

%

na

Diluted EPS

4.14

3.11

33.1

%

na

Operating cash flow

398

384

3.8

%

na

Non-GAAP Metrics:

Adjusted revenues

$

1,676

$

1,631

2.8

%

1.8

%

Adjusted EBITDA excluding divested operation

466

438

6.4

%

4.4

%

Adjusted EPS

4.37

3.53

23.8

%

na

Free cash flow

378

347

8.9

%

na

na=not available.

CONTRACT VALUE HIGHLIGHTS

Global Technology Sales Contract Value FX Neutral (GTS CV): $4.0 billion, ~flat Sequentially, +1.1% YoY Global Business Sales Contract Value FX Neutral (GBS CV): $1.3 billion, +1.2% Sequentially, +3.3% YoY SEGMENT RESULTS HIGHLIGHTS

Our segment results for the three months ended June 30, 2026 were as follows:

(Unaudited; $ in millions)

Insights

Conferences

Consulting

Revenues

$

1,290

$

244

$

142

Inc/(Dec)

2.1

%

15.5

%

(8.8

)%

Inc/(Dec) - FX neutral

1.0

%

14.2

%

(8.8

)%

Gross contribution

$

999

$

145

$

54

Inc/(Dec)

4.0

%

19.6

%

(12.6

)%

Contribution margin

77.5

%

59.5

%

37.9

%

Additional details regarding our segment results can be obtained from the earnings supplement, our quarterly report on Form 10–Q filed with the SEC on August 4, 2026 and our webcast.

Certain financial metrics contained in this Press Release are considered non-GAAP financial measures. Definitions of these non-GAAP financial measures are included in this Press Release under “Non-GAAP Financial Measures” and the related reconciliations are under “Supplemental Information — Non-GAAP Reconciliations.” In this Press Release, some totals may not add due to rounding. The percentage changes are based on the unrounded whole number and recalculation based on millions may yield a different result.

ABOUT GARTNER

Gartner, Inc. (NYSE: IT) delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization’s mission-critical priorities.

FORWARD-LOOKING STATEMENTS

Statements contained in this press release regarding the Company’s growth and prospects, projected financial results, long-term objectives, and all other statements in this release other than recitation of historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements involve known and unknown risks, estimates, uncertainties and other factors that may cause actual results to be materially different. Such factors include, but are not limited to, the following: our ability to maintain and expand our products and services; our ability to keep pace with technological and industry developments in artificial intelligence (“AI”) and comply with evolving AI regulations; our ability to achieve continued customer renewals and achieve new contract value, backlog and deferred revenue growth in light of competitive pressures; our ability to grow or sustain revenue from individual customers; our ability to expand or retain our customer base; our ability to carry out our strategic initiatives and manage associated costs; the timing of conferences and meetings, in particular our Gartner Symposium/Xpo series; our ability to achieve and effectively manage growth, including our ability to integrate our acquisitions and consummate and integrate future acquisitions; our ability to attract and retain a professional staff of analysts and consultants as well as experienced sales personnel upon whom we are dependent, especially in light of labor competition; our ability to successfully compete with existing competitors and potential new competitors; our ability to enforce and protect our intellectual property rights; the impact of cybersecurity incidents or other disruptions to our information systems; our ability to pay our debt obligations; the impact of global economic and geopolitical conditions, including inflation (and related monetary policy by governments in response to inflation) and recession; uncertain effects, both direct and indirect, of changes and volatility in tariffs and trade policies; risks associated with the creditworthiness, budget cuts, priorities and shutdown of governments and agencies; additional risks associated with international operations, including foreign currency fluctuations; the impact on our business resulting from changes in international conditions, including those resulting from tensions in the Middle East, the war in Ukraine and current and future sanctions imposed by governments or other authorities; the impact of restructuring and other charges on our businesses and operations; our ability to meet sustainability commitments and comply with applicable regulatory requirements, as well as potential reactions by customers to these commitments; the impact of changes in tax policy (including global minimum tax legislation) and heightened scrutiny from various taxing authorities globally; changes to laws and regulations; and other risks and uncertainties described under “Risk Factors” in our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, which can be found on Gartner’s website at https://investor.gartner.com and the SEC’s website at www.sec.gov. Forward-looking statements included herein speak only as of the date hereof and Gartner disclaims any obligation to revise or update such statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events or circumstances, except as required by applicable law.

NON-GAAP FINANCIAL MEASURES

Certain financial measures used in this Press Release are not defined by U.S. generally accepted accounting principles (“GAAP”) and as such are considered non-GAAP financial measures. We provide these measures to enhance the user’s overall understanding of the Company’s current financial performance and the Company’s prospects for the future. Investors are cautioned that these non-GAAP financial measures may not be defined in the same manner by other companies and, as a result, may not be comparable to other similarly titled measures used by other companies. Also, these non-GAAP financial measures should not be construed as alternatives, or superior, to other measures determined in accordance with GAAP. The non-GAAP financial measures used in this Press Release are defined below.

Adjusted Revenues: Represents GAAP revenues less revenues from our Digital Markets divested operation. We believe Adjusted Revenues is an important measure of our recurring operations as it provides a more accurate period-over period comparison of trends in revenues.

Adjusted EBITDA and Adjusted EBITDA Margin: Represents GAAP net income (loss) adjusted for: (i) interest expense, net; (ii) tax provision (benefit); (iii) gain on event cancellation insurance claims, as applicable; (iv) other (income) expense, net; (v) stock-based compensation expense; (vi) depreciation, amortization, and accretion; (vii) goodwill impairment and other asset impairments, as applicable, (viii) workforce reduction expenses and certain other non-recurring items and (ix) gain/loss on divestitures, as applicable. Adjusted EBITDA Margin represents Adjusted EBITDA divided by GAAP Revenue. We believe Adjusted EBITDA and Adjusted EBITDA Margin are important measures of our recurring operations as they exclude items not representative of our core operating results.

Adjusted EBITDA Excluding Divested Operation and Adjusted EBITDA Margin Excluding Divested Operation: Represents Adjusted EBITDA as defined above less EBITDA from our Digital Markets divested operation. Adjusted EBITDA Margin Excluding Divested Operation represents Adjusted EBITDA Excluding Divested Operation divided by Adjusted Revenue. We believe Adjusted EBITDA Excluding Divested Operation and Adjusted EBITDA Margin Excluding Divested Operation are important measures of our recurring operations as it provides a more accurate and consistent period-over period comparison of our results.

Adjusted Net Income and Adjusted EPS: Represents GAAP net income (loss) and diluted net income (loss) per share adjusted for the impact of certain items directly related to acquisitions and other non-recurring items. These adjustments include (on a per share basis, in the case of Adjusted EPS): (i) the amortization of acquired intangibles*; (ii) workforce reduction expenses and other non-recurring items; (iii) gain on event cancellation insurance claims, as applicable; (iv) the non-cash (gain) loss on de-designated interest rate swaps, as applicable; (v) goodwill impairment and other asset impairments, as applicable, (vi) gain/loss on divestitures, as applicable. and (vii) the related tax impact. We believe Adjusted Net Income and Adjusted EPS are important measures of our recurring operations as they exclude items that may not be indicative of our core operating results.

* The Company excludes amortization of acquired intangibles because it is generally a fixed non-cash expense that can be significantly impacted by the timing and/or size of acquisitions and management does not use it to evaluate core operating results. Although the Company excludes the amortization of acquired intangibles from Adjusted Net Income and Adjusted EPS, management believes that it is important for investors to understand that such intangible assets were recorded as part of acquisition accounting and contribute to revenue generation.

Free Cash Flow: Represents cash provided by operating activities determined in accordance with GAAP less payments for capital expenditures. We believe Free Cash Flow is an important measure of the recurring cash generated by the Company’s core operations that may be available to be used to repay debt obligations, repurchase our stock, invest in future growth through new business development activities, or make acquisitions.

Foreign Currency Neutral (FX Neutral): We provide foreign currency neutral dollar amounts and percentages for our contract values, revenues, certain expenses, and other metrics. These foreign currency neutral dollar amounts and percentages eliminate the effects of exchange rate fluctuations and thus provide a more accurate and meaningful trend in the underlying data being measured. We calculate foreign currency neutral dollar amounts by converting the underlying amounts in local currency for different periods into U.S. dollars by applying the same foreign exchange rates to all periods presented.

SUPPLEMENTAL INFORMATION - NON-GAAP RECONCILIATIONS

The tables below provide reconciliations of certain Non-GAAP financial measures used in this Press Release with the most directly comparable GAAP measure. See “Non-GAAP Financial Measures” above for definitions of these measures.

Reconciliation - GAAP Revenues to Adjusted Revenues

(Unaudited; $ in millions)

Three Months Ended June 30,

2026

2025

Total revenues

$

1,676

$

1,686

Less: Divested operation revenues

—

(56

)

Adjusted revenues

$

1,676

$

1,631

Reconciliation - GAAP Net Income to Adjusted EBITDA Excluding Divested Operation

(Unaudited; $ in millions)

Three Months Ended June 30,

2026

2025

GAAP net income

$

275

$

241

Interest expense, net

22

12

Other expense (income), net

2

(2

)

Tax provision

79

77

Operating income

379

327

Adjustments:

Stock-based compensation expense (a)

41

43

Depreciation, amortization and accretion (b)

45

51

Loss on impairment of lease related assets (c)

—

1

Workforce reduction expenses and other non-recurring items (d)

—

22

Gain from sale of divested operation (e)

1

—

Adjusted EBITDA

$

466

$

443

Less: Divested operation adjusted EBITDA (f)

—

(6

)

Adjusted EBITDA excluding divested operation

$

466

$

438

(a)

Consists of costs for stock-based compensation awards.

(b)

Includes depreciation expense, amortization of intangibles and accretion on asset retirement obligations.

(c)

Includes impairment loss for lease related assets.

(d)

Consists of workforce reduction expenses, direct and incremental expenses related to acquisitions and divestitures, facility-related exit costs and other non-recurring items, if applicable.

(e)

Consists of an adjustment to the gain from the February 2026 sale of our divested operation.

(f)

Divested operation adjusted EBITDA is calculated as divested operation contribution minus certain direct Selling, General, and Administrative expenses. It excludes allocations for corporate support services and other indirect costs that benefited the business.

Reconciliation - GAAP Net Income and GAAP Net Income per Diluted Share to Adjusted Net Income and Adjusted EPS

(Unaudited; $ in millions, except per share amounts)

Three Months Ended June 30,

2026

2025

Amount

Per Share

Amount

Per Share

GAAP net income and GAAP net income per diluted share

$

275

$

4.14

$

241

$

3.11

Acquisition and other adjustments:

Amortization of acquired intangibles (a)

20

0.30

20

0.26

Workforce reduction expenses and other non-recurring items (b), (c)

1

0.02

23

0.29

Gain from sale of divested operation (d)

1

0.01

—

—

Loss on impairment of lease related assets (e)

—

—

1

0.01

Tax impact of adjustments (f)

(6

)

(0.10

)

(11

)

(0.14

)

Adjusted net income and Adjusted EPS (g)

$

291

$

4.37

$

273

$

3.53

(a)

Consists of non-cash amortization from acquired intangibles.

(b) 

Consists of workforce reduction expenses, direct and incremental expenses related to acquisitions and divestitures, facility-related exit costs and other non-recurring items, if applicable.

(c) 

Includes the amortization of deferred financing fees, which are recorded in Interest expense, net in the Company’s accompanying Condensed Consolidated Statements of Operations.

(d)

Consists of an adjustment to the gain from the February 2026 sale of our divested operation.

(e)

Includes impairment loss for lease related assets.

(f)

The blended effective tax rates on the adjustments were approximately 29.1% and 25.5% for the three months ended June 30, 2026 and 2025, respectively.

(g)

Adjusted EPS was calculated based on 66.6 million and 77.4 million diluted shares for the three months ended June 30, 2026 and 2025, respectively.

Reconciliation - GAAP Cash Provided by Operating Activities to Free Cash Flow

(Unaudited; $ in millions)

Three Months Ended June 30,

2026

2025

GAAP cash provided by operating activities

$

398

$

384

Cash paid for capital expenditures

(20

)

(36

)

Free Cash Flow

$

378

$

347

  GARTNER, INC.

Condensed Consolidated Statements of Operations

(Unaudited; in millions, except per share data)

  Three Months Ended

June 30,

2026

2025

Revenues:

Insights

$

1,289.8

$

1,263.6

Conferences

244.2

211.4

Consulting

141.9

155.6

Other

—

55.9

Total revenues

1,675.9

1,686.5

Costs and expenses:

Cost of services and product development

487.0

531.7

Selling, general and administrative

764.6

777.0

Depreciation

25.1

30.5

Amortization of intangibles

20.0

20.2

Gain from sale of divested operation

0.7

—

Total costs and expenses

1,297.4

1,359.4

Operating income

378.5

327.1

Interest expense, net

(22.3

)

(11.8

)

Other (expense) income, net

(1.6

)

2.5

Income before income taxes

354.6

317.8

Provision for income taxes

79.1

77.0

Net income

$

275.5

$

240.8

Net income per share:

Basic

$

4.14

$

3.12

Diluted

$

4.14

$

3.11

Weighted average shares outstanding:

Basic

66.5

77.2

Diluted

66.6

77.4

Source: Gartner, Inc.
Gartner-IR

More News From Gartner, Inc.

Mega-cap tech stocks have helped large caps dominate small-cap ETF flows and performance for years. However, this year a shift is taking place. In 2026, small-cap index ETFs are outperforming their large-cap peers as the market has broadened out.

Key Takeaways Small-cap ETF SPSM rose 21% year to date through late July, beating the S&P 500 Index by more than 1,300 basis points.  Technology-focused PSCT’s 33% gain has been boosted by lesser-known companies. Free cash flow ETF SFLO’s 26% weight in technology has helped it to deliver a 29% year-to-date return. Sector Diversification Drives Small-Cap ETF Returns  To understand why small-cap ETFs are surging, investors should look under the hood. Take two low-cost core ETFs: the State Street SPDR Portfolio S&P 500 ETF (SPYM) and the State Street SPDR Portfolio S&P 600 Small Cap ETF (SPSM).

SPYM is concentrated, with information technology (IT) representing 36% of fund assets. By contrast, SPSM offers a significantly more balanced, economically sensitive profile. 

Financials lead SPSM at 19% of assets and have added value. The sector exposure is closely followed by industrials at 18%.  Meanwhile, technology makes up just 12% of the small-cap ETF’s assets. When market rallies broaden into cyclical corners of the economy, SPSM’s heavier tilts toward banks, construction, and machinery companies offer a tailwind.

Despite its strong performance, many investors have not recently turned to SPSM. The ETF gathered just over $1 billion this year. This is miniscule compared to SPYM’s $52 billion cash haul. 

Core & Cash Flow ETF Comparison Fund Name Ticker Info Tech Sector Weight (%) YTD Performance (%) SPDR Portfolio S&P 500 ETF SPYM 36% 7.7% SPDR Portfolio S&P 600 Small Cap ETF SPSM 12% 20.6% VictoryShares Free Cash Flow ETF VFLO 23% 28.0% VictoryShares Small Cap Free Cash Flow ETF SFLO 26% 29.4% As of July 29, 2026

Small-Cap Tech Outpaces Mega-Cap Giants Even within the tech sector, small caps are having an impressive year. The Invesco S&P SmallCap Information Technology ETF (PSCT) is up an impressive 37% year to date, comfortably outstripping the Technology Select Sector SPDR Fund (XLK) and its 19% return.

XLK relies heavily on mega caps like Microsoft and NVIDIA. However, PSCT’s rally has been powered by lesser-known companies such as electronic manufacturing services provider Plexus and satellite communications specialist ViaSat. Yet, PSCT manages nearly $500 million in assets, significantly less than $115 billion in XLK.

Free Cash Flow Factor ETFs Performing Well  The small-cap outperformance trend extends into factor-based strategies as well. The VictoryShares Small Cap Free Cash Flow ETF (SFLO) is up 29% year-to-date, modestly outpacing its large-cap counterpart, the VictoryShares Free Cash Flow ETF (VFLO), which has posted a still-healthy 28% gain.  

While VFLO maintains a hefty 23% allocation to information technology, SFLO leans in even further with a 26% exposure to technology. Strong performers within SFLO’s tech sleeve this year include Extreme Networks, RingCentral, and Penguin Solutions. 

By focusing on high-quality cash flow generators, SFLO highlights how rules-based factor discipline can uncover hidden strength. SFLO will turn three years old at the end of 2026. However, with $650 million of assets, it is less known than the $9 billion VFLO. 

Analyzing What is Under the Hood of Small-Cap ETFs Investors looking to diversify beyond mega-cap concentration risk would do well to inspect what’s under the hood. As market breadth expands, small-cap index ETFs are proving they belong as part of the asset allocation discussion. But it pays to look inside an ETF. 

For more news, information, and analysis visit the Thematic Investing Content Hub.

VettaFi LLC (“VettaFi”) is the index provider for SFLO and VFLO, for which it receives an index licensing fee. However, SFLO and VFLO are not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of SFLO and VFLO.

SANTA CLARA, Calif., July 31, 2026 (GLOBE NEWSWIRE) --

Netskope (NASDAQ: NTSK), a leader in modern security and networking for the cloud and AI era, today announced that Gartner, Inc. has recognized the company for the third consecutive year as a Leader in the Gartner Magic Quadrant for Secure Access Service Edge (SASE) Platforms. Netskope is positioned highest in Ability to Execute in the new report.

In the companion SASE Platforms Critical Capabilities report, a comparative research report that scores competing technology products or services against a specific set of critical differentiators, Netskope is the only vendor ranked as the highest scoring for three Use Cases, including: Foundational SASE Platform Use Case (4.24/5), Zero Trust SASE Platform Use Case (4.43/5), and the new Sovereign SASE Use Case (4.16/5).

Netskope helps organizations modernize by converging critical security, network, analytics, and AI products into a powerful, unified platform, Netskope One. The architecture of Netskope One applies zero trust principles and AI innovations to optimize access, protect data wherever it moves, stop threats, and enable secure, work-from-anywhere connectivity. Netskope One is powered by NewEdge, the private cloud infrastructure that underpins Netskope’s delivery of security, networking, analytics, and AI services with fast inference and proven low latency for AI use and agentic workflows, preventing traditional trade-offs between security and performance.

“We believe being named a Leader again in SASE Platforms, and positioned highest in Ability to Execute, reflects the trust customers place in Netskope to modernize their security and networking for today’s AI-first business requirements,” said Sanjay Beri, CEO and co-founder, Netskope. “We built Netskope One so customers never have to choose between AI-ready security and network performance. Along with our continued innovation in data protection, data sovereignty controls, and extending SASE functionality with agentic operations to automate SASE workflows, we feel this recognition underscores how we’re successfully delivering on that vision at scale.”

In our view, Netskope’s recognition in leading SASE, SSE, and AI capabilities all align to Gartner forecast1, and strategic planning assumptions2 for the SASE market, which include:

By 2028, 50% of new SASE deployments will be based on a single-vendor SASE platform offering (up from 30% in 2025), and 70% of SD-WAN purchases will be part of these single-vendor offerings.By 2028, vendors lacking a feature-rich SASE platform with strong AI controls and key integrations (such as data security posture management [DSPM] and secure enterprise browser [SEB]) will need to partner with others to stay competitive.By 2027, 30% of organizations will require comprehensive sovereignty of their cloud security controls to address continued geopolitical turmoil.
For more on today’s announcement, download a complimentary copy of the 2026 Gartner Magic Quadrant for SASE Platforms from Netskope.

Gartner Disclaimer

Gartner, Magic Quadrant for SASE Platforms, Jonathan Forest, Andrew Lerner, John Watts, 28 July 2026.

Gartner, Critical Capabilities for SASE Platforms, Jonathan Forest, Andrew Lerner, Thomas Lintemuth, John Watts, 29 July 2026.

Gartner and Magic Quadrant are trademarks of Gartner, Inc. and/or its affiliates.

Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose.

About Netskope
Netskope (NASDAQ: NTSK), a leader in modern security and networking for the cloud and AI era, addresses the needs of both security and networking teams by providing optimized access and real-time, context-based security for the AI ecosystem inclusive of agents, applications, tools, LLMs, people, devices, and data. Thousands of customers, including more than 30% of the Fortune 100, trust the Netskope One platform, its Zero Trust Engine, and its powerful NewEdge network to reduce risk and gain full visibility and control over cloud, AI, SaaS, web, and private applications — providing security and accelerating performance without trade-offs.

Learn more at netskope.com, on LinkedIn, and on Instagram.

Forward-Looking Statements
This press release contains forward-looking statements regarding technology forecasts based on third-party analyst reports (including Gartner). While we believe these third-party sources are reputable and reliable, we have not independently verified the data or the underlying assumptions on which third-party forecasts are based. Third-party forecasts involve inherent uncertainties and assumptions, and actual outcomes may differ materially from those expressed or implied in these reports.

Media Relations Contacts:
[email protected]

Investor Relations Contacts:
[email protected]

1 Gartner, Forecast Analysis: Secure Access Service Edge, Worldwide, 2025-2030, Charanpal Bhogal, Neil MacDonald, Andrew Lerner, Jonathan Forest, Charlie Winckless, 15 May 2026.

2 Gartner, The SASE Geopatriation Pivot: Addressing the Sovereign-First Era, Charanpal Bhogal, Charlie Winckless, Theo de Feligonde, 11 June 2026.

Shares of the IT research company Gartner (IT +6.30%) were on the rise today, as investor optimism in the tech stock continued to gain momentum.

Gartner's shares rose by as much as 6% today and were up by 5.8% as of 11:41 a.m.

Image source: Getty Images.

An undervalued tech stock? Gartner's stock has tumbled 53% over the past 12 months, as investors have grown concerned that the company's technology research and insights will be displaced by artificial intelligence.

But the steep decline has some investors wondering whether Gartner is undervalued. The company beat Wall Street's consensus earnings estimate of $2.99 per share in the first quarter, instead reporting adjusted earnings of $3.32 per share.

The company will release its second-quarter results next week, on Aug. 4, and investors may be hoping for another earnings beat -- and snatching up shares in anticipation.

Today's Change

(

6.30

%) $

9.82

Current Price

$

165.66

Wait and see While it's understandable that some investors want to buy up Gartner stock while it looks like a sale, I'd still wait a few more quarters to see how the company is countering potential AI disruption.

Investors will get a clearer view of how the company is doing when its second-quarter results drop next week. It's worth waiting a little longer for a clearer perspective, especially if you're on the fence about buying Gartner right now.

Chris Neiger has no position in any of the stocks mentioned. The Motley Fool recommends Gartner. The Motley Fool has a disclosure policy.

Wall Street expects a year-over-year increase in earnings on lower revenues when Gartner (IT - Free Report) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on August 4. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis technology information and analysis company is expected to post quarterly earnings of $3.77 per share in its upcoming report, which represents a year-over-year change of +6.8%.

Revenues are expected to be $1.65 billion, down 2.4% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.97% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Gartner?For Gartner, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.48%.

On the other hand, the stock currently carries a Zacks Rank of #4.

So, this combination makes it difficult to conclusively predict that Gartner will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Gartner would post earnings of $2.99 per share when it actually produced earnings of $3.32, delivering a surprise of +11.04%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Gartner doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

On July 13, the Stanford Digital Economy Lab published an 88-word statement titled “A Statement on AI’s Transformation of the Economy,” signed by more than 200 economists, executives, and researchers, including 16 Nobel laureates. The letter warns that AI “may become radically more powerful over the next 10 years,” potentially driving a shift “larger than the Industrial Revolution” but on a compressed timeline, carrying risks “including large-scale job displacement” alongside “major gains in living standards.”

The striking element is who signed it. Daron Acemoglu and Simon Johnson, both at MIT and joint 2024 Nobel economics laureates, have long argued that AI’s productivity gains are overhyped. Their names on this document mark what organizer Erik Brynjolfsson of Stanford called “a notable change in the profession.”

The Real-World Backdrop The threat of AI-driven job eliminations has no shortage of evidence. For instance, Oracle (NYSE:ORCL | ORCL Price Prediction) has eliminated about 21,000 jobs, 13% of its global workforce, with the cuts attributed to AI adoption. Amazon (NASDAQ:AMZN) cut about 30,000 positions, though AI’s role there is debated.

Oracle stock shows the tension: the company’s Cloud Infrastructure revenue grew 93% year over year (YoY) to $5.79 billion in Q4 FY2026, remaining performance obligations ballooned 363% to $638 billion, and restructuring charges hit $823 million in the quarter alone. Co-CEO Clay Magouyrk stated that Oracle’s autonomous software has been “key to reducing human labor and human error in our datacenters.” Oracle stock is down 35% year to date (YTD).

What the Letter Says Organized by Anton Korinek (University of Virginia, currently embedded with Anthropic), Brynjolfsson, Ajay Agrawal (University of Toronto), and Tom Cunningham (METR), the statement names no specific policies. It calls on economists, policymakers, and technology leaders to build “the incentives, guardrails, and institutions needed to steer AI.”

Signatories include Eric Schmidt, Reid Hoffman, Joseph Stiglitz, Jeff Dean of Google DeepMind, Jack Clark of Anthropic, and Sarah Friar of OpenAI. Korinek’s framing is direct: “Steam, electricity, and computers each gave societies decades to adapt; AI may give us only a few years.”

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Amazon didn't make the cut. Grab the names FREE today.

The Evidence Cuts Both Ways Aaron Terrazas, former Glassdoor chief economist, described sustained white-collar payroll contraction as “without precedent outside of a recession.” Yet, headline unemployment sits at 4.2% in June, and Job Openings and Labor Turnover Survey (JOLTS) openings rebounded to 7.59 million in May. The slack is showing up as underemployment and workforce exits.

The IMF finds AI adoption still concentrated among a minority of workers, while a Harvard/INSEAD/University of Toronto study documented VC-backed startups hiring fewer entry-level workers. Anthropic CEO Dario Amodei has claimed AI could eliminate up to half of entry-level white-collar jobs within five years. Acemoglu has told reporters he hasn’t abandoned his doubts about industry’s most optimistic timelines.

What Investors Can Watch For what it’s worth, some AI-driven cuts are already reversing. Gartner (NYSE:IT) projects that about half of AI-related job cuts will be reversed by 2027, and Klarna (NYSE:KLAR) pulled back on replacing customer service with AI. The capital tells the other side of the story, as Alphabet‘s (NASDAQ:GOOGL) Google (which has implemented ongoing waves of job reductions) has guided 2026 capital expenditures to $175 to $185 billion, Amazon plans about $200 billion, and Oracle expects to raise roughly $40 billion in FY2027 for further buildout.

So far, it appears that AI-driven job cuts haven’t caused much consternation for mega-cap stakeholders. Google Cloud revenue grew 63% YoY to $20.03 billion in Q1 2026, with backlog nearing $460 billion. Alphabet stock is up 84% over the past year, while Amazon stock is up 8% over the same span.

Still, the laureates’ statement calls for preparation. Investors could watch two signals over the next two quarters: whether white-collar payroll contraction spreads into the June jobs revision beyond its current 158.98 million total, and whether Oracle’s restructuring template migrates into Alphabet’s or Amazon’s operating segments. If it does, the tsunami Brynjolfsson referenced may arrive faster than the models suggest.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Amazon didn't make the cut. Grab the names FREE today.

Contact [email protected] for any questions or corrections.

SUNNYVALE, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- eGain Corporation (NASDAQ: EGAN), the AI knowledge platform for customer service, today announced it has been named a Leader in the inaugural Gartner® Magic Quadrant™ for Knowledge Management Systems for Customer Service.

Key Takeaways Ouster expects EBITDA profitability milestones during 2027 through balanced growth and cost control.OUST targets 30% to 50% annual revenue growth and posted 44% year-over-year growth excluding Stereolabs. Ouster aims for 35% to 40% GAAP gross margins while limiting operating expense growth to 5% to 8%. Ouster, Inc.’s (OUST - Free Report) most important financial milestone is to reach EBITDA breakeven, and the company's roadmap suggests that no single metric will determine when it gets there. Instead, profitability depends on a combination of sustained revenue growth, healthy gross margins and disciplined operating expenses.

Revenue growth is expected to remain the primary driver. Ouster continues to target annual revenue growth of 30% to 50%, supported by product innovation and expanding adoption across its sensing and perception portfolio. Even excluding the contribution from the Stereolabs acquisition, the company delivered 44% year-over-year revenue growth, demonstrating that the underlying business continues to scale at a strong pace.

However, higher revenues alone are unlikely to deliver EBITDA breakeven. The company also aims to maintain GAAP gross margins in the 35% to 40% range, allowing more of every incremental revenue dollar to contribute toward covering fixed costs. At the same time, operating expenses are expected to increase by only 5% to 8% from 2025 levels, despite investments in innovation and the integration of Stereolabs. This operating discipline is designed to create meaningful leverage as revenues continue to expand.

Taken together, these factors point to a gradual but improving EBITDA profile. If Ouster continues delivering strong revenue growth while maintaining margin performance and keeping operating expense growth under control, the company expects to begin reaching EBITDA profitability milestones during 2027. Continued innovation serves as the catalyst that supports each of these financial objectives and strengthens the path toward breakeven. OUST carries a Zacks Rank #3 (Hold) at present.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Competitors' Efforts to Improve Their Respective PerformanceInnoviz Technologies Ltd. (INVZ - Free Report) reported a first-quarter gross margin of approximately negative 22%, impacted by revenue mix and lower fixed-cost absorption. Innoviz expects margins to improve as production volumes ramp up later this year. Innoviz’s NREs accounted for about 70% of 2025 revenues, and the company expects LiDAR revenues and gross margins to rise as programs reach SOP and new wins expand.

indie Semiconductor, Inc. (INDI - Free Report) reported first-quarter revenues of $55.5 million, up about 3% year over year, with core business revenues of $34.1 million growing more than 20% sequentially. indie reduced its non-GAAP operating loss to $11.1 million from $15.1 million a year ago while keeping operating expenses in line with guidance. indie expects second-quarter operating expenses of about $38 million and believes its balance sheet and Wuxi sale proceeds will support its path to profitable growth through 2026.

OUST’s Price Performance, Valuation and EstimatesOuster has outperformed the Zacks Electronics - Semiconductor industry year to date. OUST has gained 75.4% against the industry decline of 14.1%.  

Image Source: Zacks Investment Research

From a valuation perspective, Ouster appears overvalued. Going by its price/sales ratio, the company is trading at a forward sales multiple of 8.91, higher than the industry’s 3.97.

Image Source: Zacks Investment Research

 
The Zacks Consensus Estimate for 2026 and 2027 loss per share has widened by 2 cents each in the past 60 days.

Image Source: Zacks Investment Research

NEW YORK--(BUSINESS WIRE)--Grafana Labs, the company behind the open observability cloud, today announced it has been named a Leader in the Gartner® Magic Quadrant™ for Observability Platforms for the third consecutive year, and positioned furthest on the Completeness of Vision axis for the second year running. We believe this placement reflects where the market is headed: toward open, composable observability that helps teams in the AI era understand systems that are increasingly complex and a.

NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:

Do you currently own shares of Gartner, Inc. (NYSE: IT)?Did you purchase any of your shares prior to February 24, 2025?Do you want to discuss your rights?
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating whether certain directors and officers of Gartner, Inc. (“Gartner” or the “Company”) (NYSE: IT) breached the fiduciary duties they owe to the Company.

What To Do Next:

If you currently hold Gartner stock and would like to discuss your legal rights and options, please visit Gartner, Inc. Shareholder Investigation or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or [email protected].

About Bernstein Liebhard:

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years.

ATTORNEY ADVERTISING. © 2026 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Peter Allocco
Bernstein Liebhard LLP
https://www.bernlieb.com
(212) 951-2030
[email protected]

STAMFORD, Conn.--(BUSINESS WIRE)-- #GartnerSYM--Gartner, Inc. (NYSE: IT): What: Gartner IT Symposium/Xpo 2026 When: October 19-22, 2026 Where: Walt Disney World Resort, Orlando, Florida Details: Gartner IT Symposium/Xpo 2026 is the world's most important gathering of CIOs and other IT executives. More than 7,000 CIOs and senior leaders will explore the technology, insights and trends shaping the future of IT and business, including AI, business transformation and value, cybersecurity, customer experience, da.